Table of Contents Table of Contents
Previous Page  946 / 1631 Next Page
Information
Show Menu
Previous Page 946 / 1631 Next Page
Page Background

CAR-T

Where will they fit in?

• Current approval for third line therapy in DLBCL

• On-going trials in second line compared to high-dose therapy